On Friday, ATAI Life Sciences N.V (NASDAQ: ATAI) opened higher 5.92% from the last session, before settling in for the closing price of $1.52. Price fluctuations for ATAI have ranged from $1.02 to $2.85 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -16.02% annually for the last half of the decade. Company’s average yearly earnings per share was noted -217.14% at the time writing. With a float of $117.06 million, this company’s outstanding shares have now reached $166.03 million.
In an organization with 83 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 19.64%, operating margin of -31987.01%, and the pretax margin is -38614.5%.
ATAI Life Sciences N.V (ATAI) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ATAI Life Sciences N.V is 30.24%, while institutional ownership is 7.17%. The most recent insider transaction that took place on Sep 26 ’24, was worth 16,093,000. In this transaction 10% Owner of this company sold 2,660,000 shares at a rate of $6.05, taking the stock ownership to the 6,905,774 shares. Before that another transaction happened on May 16 ’24, when Company’s insider sold 151,303 for $1.92, making the entire transaction worth $290,502. This insider now owns 328,697 shares in total.
ATAI Life Sciences N.V (ATAI) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.12 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.16) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -217.14% per share during the next fiscal year.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
Check out the current performance indicators for ATAI Life Sciences N.V (ATAI). In the past quarter, the stock posted a quick ratio of 5.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 867.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
Let’s dig in a bit further. During the last 5-days, its volume was 3.14 million. That was better than the volume of 1.21 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 46.19%. Additionally, its Average True Range was 0.18.
During the past 100 days, ATAI Life Sciences N.V’s (ATAI) raw stochastic average was set at 63.04%, which indicates a significant increase from 62.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 120.96% in the past 14 days, which was higher than the 75.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2470, while its 200-day Moving Average is $1.5556. However, in the short run, ATAI Life Sciences N.V’s stock first resistance to watch stands at $1.7400. Second resistance stands at $1.8700. The third major resistance level sits at $2.0300. If the price goes on to break the first support level at $1.4500, it is likely to go to the next support level at $1.2900. The third support level lies at $1.1600 if the price breaches the second support level.
ATAI Life Sciences N.V (NASDAQ: ATAI) Key Stats
There are currently 167,802K shares outstanding in the company with a market cap of 286.16 million. Presently, the company’s annual sales total 310 K according to its annual income of -40,220 K. Last quarter, the company’s sales amounted to 40 K and its income totaled -26,290 K.
